500 episodes

Health Professional radio gives you access to interesting and entertaining interviews, news updates, professional profiles, research updates on a broad range of topics related to health.

Health Professional Radio - Podcas‪t‬ Vertical Internet Media 454422

    • Health & Fitness
    • 4.0 • 1 Rating

Health Professional radio gives you access to interesting and entertaining interviews, news updates, professional profiles, research updates on a broad range of topics related to health.

    One in Seven Black Men Will Be Diagnosed with Prostate Cancer in the U.S.

    One in Seven Black Men Will Be Diagnosed with Prostate Cancer in the U.S.

    Dr. Arnold Bullock, MD, Alan A. and Edith L. Wolff Distinguished Professor of Urology at Washington University School of Medicine, Siteman Cancer Center, and Barnes-Jewish Hospital discusses important information on what all men, particularly black men should know about prostate cancer, what they can do to better understand why this population of men is disproportionately affected, and about the prostate cancer screening process. He is joined by Dr. Lannis Hall, Director of Radiation Oncology, Siteman Cancer Center at Barnes-Jewish St. Peters Hospital who discusses prostate cancer risk factors, signs and symptoms, and advice on how men and their loved ones can advocate for their health to ensure earlier diagnosis and treatment of the disease.

    • 10 min
    Survey Looks at Employee Mental Health in the Age of COVID-19

    Survey Looks at Employee Mental Health in the Age of COVID-19

    Returned guest, Ken Cahill, CEO of SilverCloud Health, a digital mental health platform, discusses a new employee mental health survey of 1,288 US-based individuals that examined employees’ mental health, wellbeing, and attitudes toward employer-sponsored mental health services and digitally delivered care. Data shows that many are struggling due to increased stress related to the COVID-19 pandemic.

    Ken Cahill is the CEO and co-founder of SilverCloud Health with offices in Boston, Dublin, and London. SilverCloud is the world’s leading digital mental health platform. It enables the delivery of clinically validated digital therapeutic care programs that are proven to significantly improve clinical outcomes, and increase access and scale while reducing care delivery costs. Prior to founding SilverCloud Health, Ken held senior positions in several multinational companies including, Dell, HP, and Gateway. Ken recently received the 2018 MedTech Boston 40 under 40 award and holds a BSc. degree in computing, a diploma in new business, and a certificate in company direction from the Institute of Directors.

    • 11 min
    Cancer Patient Experience with FDA Approved CAR T Therapy

    Cancer Patient Experience with FDA Approved CAR T Therapy

    Milton, a 68-year-old from Beulah, AL shares his experience of becoming 98 percent cancer free after his participation in a clinical trial for a recently FDA-approved CAR T cell therapy called BREYANZI® (lisocabtagene maraleucel) from Bristol-Myers Squibb. He was treated for a diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma.

    Retired contractor-turned pastor, Auburn University sports fanatic and family man, Milton, was diagnosed with diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma – in 2015. After failed chemotherapy, Milton enrolled in a clinical trial for the FDA approved CAR T cell therapy treatment called Breyanzi and a month later, was 98 percent cancer free. For Milton, it was his faith – including his faith in his treatment and care team – along with a strong family support system and winning attitude that helped him manage life since diagnosis: "You’ve got to have a belief system bigger than yourself; believe in what we don’t see."Today, Milton remains cancer free and has been able to witness life's most important moments, like the recent birth of his second great grandchild – something he never anticipated being a part of. When he’s not serving his local church community as a pastor, he enjoys hosting Auburn game days with his family – including two adopted children, seven grandchildren and two great grandchildren.

    Retired contractor-turned pastor, Auburn University sports fanatic and family man, Milton, was diagnosed with diffuse large B-cell lymphoma (DLBCL) – one of the most common types of non-Hodgkin’s lymphoma – in 2015. After failed chemotherapy, Milton enrolled in a clinical trial for the FDA approved CAR T cell therapy treatment called Breyanzi and a month later, was 98 percent cancer free. For Milton, it was his faith – including his faith in his treatment and care team – along with a strong family support system and winning attitude that helped him manage life since diagnosis: "You’ve got to have a belief system bigger than yourself; believe in what we don’t see."Today, Milton remains cancer free and has been able to witness life's most important moments, like the recent birth of his second great grandchild – something he never anticipated being a part of. When he’s not serving his local church community as a pastor, he enjoys hosting Auburn game days with his family – including two adopted children, seven grandchildren and two great grandchildren.

    • 8 min
    Outcomes4Me - Cancer Patient and Survivor App

    Outcomes4Me - Cancer Patient and Survivor App

    Maya Said shares her personal cancer story and how she came to co-found the Outcomes4Me free app to help simplify the process and improve outcomes for breast cancer patients and survivors. It connects patients to a platform that leverages AI and machine learning to analyze and consolidate medical records – regardless of provider, network, or geography – to gain access to clinical trials, approved treatments, and tools for symptom management. They have recently announced a partnership with Vanderbilt-Ingram Cancer Center to pilot a first-of-a-kind integrated survivorship platform for breast and prostate cancer patients. She talks about the uphill battle cancer patients are facing due to COVID-19 including delayed screenings and essential appointments and why now, more than ever, there needs to be a single source of truth to ensure patients are staying on top of their treatment plans.

    Maya spent the last 15 years working in healthcare, primarily in the pharmaceutical industry with a focus on increasing innovation and access. Despite her extensive experience with healthcare systems globally, it wasn't until she first became a patient herself that she realized much more can be done to improve outcomes and better serve the needs of patients. An engineer and scientist by training, she strongly believes that technology combined with early patient input can address many of the gaps patients experience today in navigating the healthcare system. Her conviction that technology-based solutions that empower patients can lead to better outcomes led her to create Outcomes4Me.Prior to founding the company, she spent many years as a senior pharmaceutical executive at both Novartis and Sanofi leading global functions, including Market Access, Policy, R&D Strategy and Business Development. Earlier in her career, she was a Principal at the Boston Consulting Group and a founding member of its Strategy Institute.Maya trained at the Massachusetts Institute of Technology (MIT), earning dual degrees in Biology and Electrical Engineering and Computer Science (EECS) with a minor in Economics. She also holds a Master of Science in Toxicology, a Master of Engineering in Electrical Engineering and Computer Science and a Doctor of Science in Electrical Engineering, Computer Science and Systems Biology, all from MIT. She has authored numerous scientific and strategy articles and was honored with the Carlton E. Tucker award for teaching excellence, the Department Head Recognition Award for major contribution to the EECS Department at MIT,

    • 11 min
    Overcoming Female Incontinence

    Overcoming Female Incontinence

    Award-winning physician, Dr. Jill Rabin, Professor of Obstetrics and Gynecology at the Zucker School of Medicine at Hofstra Northwell discusses the recent book that she co-wrote with Gail Stein and Danielle O'Shaughnessy, called "MIND OVER BLADDER: A Step-By-Step Guide To Achieving Continence" (Morgan James, Dec 2020). This book seeks to educate women of all ages on the many causes of incontinence and the variety of treatment options available.

    Jill Maura Rabin, an award-winning physician, is a Professor of Obstetrics and Gynecology at the Zucker School of Medicine at Hofstra Northwell, Vice Chair for Education and Development at North Shore University Hospital and LIJ Medical Center/Northwell Health, Co-Chief of Ambulatory Care in OBGYN/Northwell Health, and Section Head of Urogynecology at LIJ/Northwell.

    Dr. Rabin, a Diplomate of the American Board of Obstetrics and Gynecology, is an active researcher, consultant, lecturer, and media spokesperson. She holds eight patents and one copyright for urogynecologic medical devices, including a confidence-building incontinence pad, a pessary for treating vaginal prolapse, and a finger protector for surgeons. In recognition of her professional accomplishments, she has received many awards and honors including the excellence in teaching award from the Association of Professors in Gynecology and Obstetrics. Widely published, she has authored four books on women's health.

    As a physician, Dr. Rabin is passionate about improving the lives of women by providing them with quality healthcare and up-to-the-minute medical information. As a teacher, she is dedicated to enhancing and enriching the medical education of her students through progressive curriculum development and active membership. It is her firm belief that empowered patients and compassionate, well-prepared physicians can work together to greatly improve women's health.

    • 11 min
    CHMP Opinion in the Area of Oncology - Hodgkin Lymphoma

    CHMP Opinion in the Area of Oncology - Hodgkin Lymphoma

    Dr. Vicki Goodman, VP, Therapeutic Area Head, Late Stage Oncology at Merck discusses the recent Phase 3 KEYNOTE-204 positive EU CHMP opinion for expanded approval of KEYTRUDA® (pembrolizumab) for the treatment of relapsed or refractory classical Hodgkin lymphoma (cHL) that meet certain criteria.


    Vicki Goodman, MD, is Vice President, Therapeutic Area Head for Late Stage Oncology at Merck. In this role, she oversees Merck’s portfolio in lung cancers, women’s cancers, hematology, and head and neck cancer. Vicki joined Merck from Bristol-Myers Squibb where most recently she was VP, Head, Clinical Development Center of Excellence. She is a hematologist and medical oncologist with 15 years of drug development experience in both government and industry. Vicki trained in internal medicine and hematology/oncology at the University of Michigan. She then served as a medical officer at FDA for over two years and subsequently worked at GlaxoSmithKline for eight years. While at GSK, Vicki took on roles of increasing responsibility and worked on a range of projects including pazopanib (Votrient) and dabrafenib (Tafinlar), alone and in combination with trametinib (Mekinist). She also led the development of several early to mid-stage oncology drug candidates. She joined BMS in January 2015 as Vice President, Development Leader for Opdivo/Yervoy in Melanoma and GU tumors. In this role, she oversaw the approval of the first I-O combination (Opdivo and Yervoy) in advanced melanoma, approval of Opdivo in adjuvant melanoma, RCC and bladder cancer, and the initiation of several key phase 3 programs. In July 2017, she was appointed to lead BMS new asset development teams, overseeing a portfolio of experimental assets between proof of concept and first regulatory approval. Vicki served as a senior advisor to the BMS women’s network, has lectured and served as a panelist in women’s oncology leadership forums including at the University of Pennsylvania Perelman School of Medicine. Vicki was profiled in Fierce Women in Biopharma in 2016 and recognized for her contributions to oncology development by Gilda’s Club NYC in 2017.

    • 9 min

Customer Reviews

4.0 out of 5
1 Rating

1 Rating

Top Podcasts In Health & Fitness

Listeners Also Subscribed To